Ibiayi Dagogo-Jack

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

JCO precision oncology

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Miriam A Bredella, Florian J Fintelmann, A John Iafrate, Ibiayi Dagogo-Jack, Keith J Dreyer, David N Louis, James A Brink, Jochen K Lennerz
Administrative Alignment for Integrated Diagnostics Leads to Shortened Time to Diagnose and Service Optimization. Radiology 312 (1) (2024)
Miriam A Bredella, Florian J Fintelmann, A John Iafrate, Ibiayi Dagogo-Jack, Keith J Dreyer, David N Louis, James A Brink, Jochen K Lennerz
Administrative Alignment for Integrated Diagnostics Leads to Shortened Time to Diagnose and Service Optimization. Radiology 312 (1) (2024)
Miriam A Bredella, Florian J Fintelmann, A John Iafrate, Ibiayi Dagogo-Jack, Keith J Dreyer, David N Louis, James A Brink, Jochen K Lennerz
Administrative Alignment for Integrated Diagnostics Leads to Shortened Time to Diagnose and Service Optimization. Radiology 312 (1) (2024)
Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, Enriqueta Felip Font, Suresh R Ramalingam, Anne S Tsao, Melissa Lynne Johnson, Francesco Gelsomino, Raymond Esper, Ernest Nadal, Michael D Offin, Mariano Provencio Pulla, Jeffrey Clarke, Maen Hussain, Gregory A Otterson, Ibiayi Dagogo-Jack, Jonathan Wade Goldman, Daniel Morgensztern, Ann Alcasid, Tiziana Usari, Paul S Wissel, Keith Wilner, Nuzhat Pathan, Svitlana Tonkovyd, Bruce E Johnson
Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAF V600 -Mutant Metastatic Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ibiayi Dagogo-Jack
Targeted Approaches to Treatment of Pleural Mesothelioma: A Review. JCO precision oncology 7 (2023)
Ibiayi Dagogo-Jack, Amanda Manoogian, Nicholas Jessop, N Zeke Georgantas, Florian J Fintelmann, Alexander Farahani, Subba R Digumarthy, Melissa C Price, Erik E Folch, Colleen M Keyes, Andrew Do, Jennifer L Peterson, Mari A Mino-Kenudson, Martha Pitman, Miguel N Rivera, Valentina Nardi, Dora Dias-Santagata, Long P Le, Anthony John Iafrate, Rebecca S Heist, Lauren R Ritterhouse, Jochen K Lennerz
Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib. JCO oncology practice (2023)
Ibiayi Dagogo-Jack, Russell W Madison, Jochen K Lennerz, Kuei-Ting Chen, Julia F Hopkins, Alexa B Schrock, Lauren L Ritterhouse, Ashley Lester, Keith A Wharton, Mari A Mino-Kenudson, Natalie Danziger, Yin P Hung, Douglas A Mata, Jeffery S Ross
Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular Landscape. JCO precision oncology 6 (2022)
Ibiayi Dagogo-Jack, Geoffrey R Oxnard, Makenzi Evangelist, Subba R Digumarthy, Jessica J Lin, Justin F Gainor, John F Murphy, Michael S Rabin, Rebecca S Heist, Alona Muzikansky, Alice T Shaw
Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse. JCO precision oncology 6 (2022)
Matthew Dankner, Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A Nebhan, Ibiayi Dagogo-Jack, Nathaniel J Myall, Georg Richtig, Jillian Wilhelmina Paulina Bracht, Marco Gerlinger, Eiji Shinozaki, Takayuki Yoshino, Daisuke Kotani, Jason R Fangusaro, Oliver Gautschi, Julien Mazieres, Jeffrey A Sosman, Edmund S Kopetz, Vivek Subbiah, Michael A Davies, Anna L Groover, Ryan J Sullivan, Keith T Flaherty, Douglas B Johnson, Andrea Benedetti, David W Cescon, Anna Spreafico, George Zogopoulos, April A N Rose
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors. JCO precision oncology 6 (2022)